| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |